Max Robotics — Global Service Robot Directory + US Certification

About

Thomas Fabian is a leading thoracic surgeon whose research centers on optimizing surgical approaches for lung cancer treatment, with a particular focus on comparing outcomes across open, video-assisted thoracoscopic (VATS), and robotic-assisted lobectomy. His most impactful contribution is the landmark Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study, first published in 2021 with 119 citations. This multi-institutional analysis provided critical comparative data on perioperative outcomes for the three surgical techniques, helping to clarify the relative benefits and risks of robotic-assisted lobectomy as its adoption surged for early-stage lung cancer. Dr. Fabian extended this work in a 2023 follow-up study (30 citations) that examined overall survival across the approaches when performed by experienced surgeons at multiple institutions, offering valuable long-term outcome data. His research has been instrumental in guiding evidence-based surgical decision-making in thoracic oncology, addressing the pressing question of whether robotic approaches offer meaningful advantages over established VATS and open techniques. By systematically evaluating both short-term complications and long-term survival, Dr. Fabian has helped shape modern thoracic surgical practice and informed the ongoing debate about optimal minimally invasive approaches for lung cancer patients.